Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap"

被引：3
|
作者：
Pitt, Bertram [1 ]
Rossignol, Patrick [2 ,3 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Lorraine, INSERM, Ctr Invest Clin Plurithemat 14 33, Inserm U1116,CHRU Nancy, Nancy, France
[3] F CRIN INI CRCT, Nancy, France
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2018年 / 31卷 / 10期
关键词：
WORSENING RENAL-FUNCTION; KIDNEY-DISEASE; HYPERKALEMIA; ASSOCIATION; GUIDELINES;
D O I：
10.1093/ajh/hpy107
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1087 / 1089
页数：3
相关论文
共 50 条
  • [21] HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION - PUMPING HEART FAILURE?
    Sokolov, A. A.
    Martsinkevich, G., I
    KARDIOLOGIYA, 2018, 58 (06) : 79 - 84
  • [22] Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Vardeny, Orly
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Lam, Carolyn S. P.
    Senni, Michele
    Shah, Sanjiv J.
    Voors, Adriaan A.
    Zannad, Faiez
    Pitt, Bertram
    Matsumoto, Shingo
    Merkely, Bela
    Zieroth, Shelley
    Yilmaz, Mehmet Birhan
    Lay-Flurrie, James
    Viswanathan, Prabhakar
    Horvat-Broecker, Andrea
    Scalise, Andrea
    Mcmurray, John J. V.
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2025, 10 (01) : 42 - 48
  • [23] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [24] Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
    Nanayakkara, Shane
    Patel, Hitesh C.
    Kaye, David M.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2018, 12
  • [25] Treatment of patients with heart failure and preserved ejection fraction
    Deswal A.
    Bozkurt B.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 516 - 528
  • [26] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [27] Irbesartan in patients with heart failure and preserved ejection fraction
    Forman D.
    Gaziano J.M.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 311 - 312
  • [28] Spironolactone in patients with heart failure and preserved ejection fraction
    Nunez, J.
    Nunez, E.
    Sanchis, J.
    REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 111 - 111
  • [29] Hypoxaemia in patients with heart failure and preserved ejection fraction
    Omar, Massar
    Omote, Kazunori
    Sorimachi, Hidemi
    Popovic, Dejana
    Kanwar, Ardaas
    Alogna, Alessio
    Reddy, Yogesh N. V.
    Lim, Kaiser G.
    Shah, Sanjiv J.
    Borlaug, Barry A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1593 - 1603
  • [30] Management of patients with heart failure and preserved ejection fraction
    Jasinska-Piadlo, Alicja
    Campbell, Patricia
    HEART, 2023, 109 (11) : 874 - 883
12345